Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Haitao Zhao, Yiran Li et al.|Hepatology International|2023Cited by 60
Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 studyGuangyu Wang, Fuquan Zhang, Zhiqun Wang et al.|Radiation Oncology|2024Cited by 20
Optimal cisplatin cycles in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapyZheng Zeng, Ke Hu, Weiping Wang et al.|Clinical & Translational Oncology|2023Cited by 12
Prospects for daily online adaptive radiotherapy for cervical cancer: Auto-contouring evaluation and dosimetric outcomesYu Zhang, Fuquan Zhang, Guangyu Wang et al.|Radiation Oncology|2024Cited by 11
A Prospective Single-Arm Study of Daily Online Adaptive Radiation Therapy for Cervical Cancer with Reduced Planning Target Volume Margin: Acute Toxicity and Dosimetric OutcomesGuangyu Wang, Fuquan Zhang, Yining Chen et al.|International Journal of Radiation Oncology*Biology*Physics|2025Cited by 10